메뉴 건너뛰기




Volumn 9, Issue 11, 2001, Pages 2921-2928

Velnacrine thiaanalogues as potential agents for treating Alzheimer's disease

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 6 CHLORO 3,4 DIHYDRO 1H THIOPYRANO[3,4 B]QUINOLIN 4 OL; ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; TACRINE; UNCLASSIFIED DRUG; VELNACRINE; 5 AMINO 3,4 DIHYDRO 1H THIOPYRAN[3,4 B]QUINOLIN 4 OL; 5 AMINO 3,4 DIHYDRO 1H THIOPYRAN[3,4 B]QUINOLIN 4 ONE; 5 AMINO 4 HYDROXY 1H THIOPYRAN[3,4 B]QUINOLIN 2 ONE; AMIDE; ATROPINE; CHLORINE; CYCLOHEXAMIDE; DONEPEZIL; GALANTAMINE; QUINOLINE DERIVATIVE; RIVASTIGMINE; SABELUZOLE; SCOPOLAMINE; SULFUR; THIOPYRANOQUINOLINE DERIVATIVE;

EID: 0034811846     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(01)00171-7     Document Type: Article
Times cited : (20)

References (43)
  • 3
    • 0003438910 scopus 로고    scopus 로고
    • (c)Giacobini, E.; Becker, R. R., Eds. Alzheimer's Disease: From Molecular Biology to Therapy. Birkhauser: Boston, 1997.
  • 17
    • 0003375622 scopus 로고    scopus 로고
    • (a)Drugs Future 1994, 19, 656.
  • 27
    • 0018870296 scopus 로고
    • Compound 1a is a commercial product, while compounds 1b-f were prepared as described in the literature. For the synthesis of compound 1b, see:
    • (1980) J. Heterocylic Chem. , vol.17 , pp. 65
    • Gray, J.1    Waring, D.R.2
  • 32
    • 0003439696 scopus 로고    scopus 로고
    • 3) δ 33.5, 38.8, 39, 52.9, 57.8, 126.6, 128.1, 128.6, 136.9, 194.4, 194.6.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.